Related Experiment Video
Updated: Jul 18, 2026
09:06
Amyloid and the Cross-Beta Architecture
Published on: February 13, 2026
Plasticity of amyloid fibrils
Ronald Wetzel1, Shankaramma Shivaprasad, Angela D Williams
1Graduate School of Medicine, University of Tennessee, Knoxville Tennessee 37920, USA. rwetzel@pitt.edu
Biochemistry
|January 3, 2007
Summary
Amyloid fibrils, like plastics, show structural malleability and polymorphism. This polymer-like behavior offers new insights into amyloid formation and potential therapeutic targets.
Area of Science:
- Biochemistry
- Materials Science
- Polymer Chemistry
Background:
- Amyloid fibrils are protein aggregates implicated in various diseases.
- Understanding amyloid fibril stability is crucial for therapeutic development.
- Traditional views consider amyloid fibrils as distinct from synthetic polymers.
Purpose of the Study:
- To characterize the structural basis of amyloid fibril stability using mutational analysis.
- To explore the analogy between amyloid fibrils and synthetic polymers.
- To re-evaluate amyloid formation mechanisms and therapeutic strategies through a polymer chemistry lens.
Main Methods:
- Mutational analysis of the Abeta (1-40) molecule.
- Characterization of amyloid fibril structural malleability and morphology.
- Comparison of amyloid fibril properties with synthetic polymers and plastics.
Main Results:
- Amyloid fibrils exhibit significant and consistent structural malleability.
- Amyloid fibrils display polymorphism (varied morphologies from one polypeptide) and isomorphism (fibrillar morphology from different polypeptides).
- These properties align amyloid fibrils more closely with synthetic polymers than globular proteins.
Conclusions:
- Viewing amyloid fibrils through the lens of polymer chemistry provides novel perspectives.
- This approach may illuminate the role of protofibrils, fibril potency, and inhibitor discovery.
- Amyloid fibrils share characteristics with historical protein-based materials and polymer science.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:11Fibril-associated Collagen
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
00:55Fibrous Proteins
Fibrous proteins are either long and narrow proteins or assemble to form long and thin structures. They contain repetitive units and usually consist of either alpha helices or beta sheets and, in rare cases, a mix of both. The amino acids in the primary structure often consist of repeating amino acid sequences. The role of fibrous proteins is primarily structural. Many are located in the extracellular matrix and are present in connective tissues to impart strength and joint mobility. They are...